{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:58:17Z","timestamp":1787065097090,"version":"build-2736575974"},"reference-count":281,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T00:00:00Z","timestamp":1717545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Neuro-Bio Ltd."}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Alzheimer\u2019s disease (AD) is a progressive neurodegenerative disease with no effective treatments, not least due to the lack of authentic animal models. Typically, rodent models recapitulate the effects but not causes of AD, such as cholinergic neuron loss: lesioning of cholinergic neurons mimics the cognitive decline reminiscent of AD but not its neuropathology. Alternative models rely on the overexpression of genes associated with familial AD, such as amyloid precursor protein, or have genetically amplified expression of mutant tau. Yet transgenic rodent models poorly replicate the neuropathogenesis and protein overexpression patterns of sporadic AD. Seeding rodents with amyloid or tau facilitates the formation of these pathologies but cannot account for their initial accumulation. Intracerebral infusion of proinflammatory agents offer an alternative model, but these fail to replicate the cause of AD. A novel model is therefore needed, perhaps similar to those used for Parkinson\u2019s disease, namely adult wildtype rodents with neuron-specific (dopaminergic) lesions within the same vulnerable brainstem nuclei, \u2018the isodendritic core\u2019, which are the first to degenerate in AD. Site-selective targeting of these nuclei in adult rodents may recapitulate the initial neurodegenerative processes in AD to faithfully mimic its pathogenesis and progression, ultimately leading to presymptomatic biomarkers and preventative therapies.<\/jats:p>","DOI":"10.3390\/ijms25116222","type":"journal-article","created":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T11:50:09Z","timestamp":1717588209000},"page":"6222","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Rodent Models of Alzheimer\u2019s Disease: Past Misconceptions and Future Prospects"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4818-5003","authenticated-orcid":false,"given":"Helen M.","family":"Collins","sequence":"first","affiliation":[{"name":"Neuro-Bio Ltd., Building F5 The Culham Campus, Abingdon OX14 3DB, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Greenfield","sequence":"additional","affiliation":[{"name":"Neuro-Bio Ltd., Building F5 The Culham Campus, Abingdon OX14 3DB, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,6,5]]},"reference":[{"key":"ref_1","unstructured":"Prince, M., Wimo, A., Guerchet, M., Ali, G.-C., Wu, Y.-T., and Prina, M. (2015). World Alzheimer Report 2015. The Global Impact of Dementia: An Analysis of Prevalence, Incidence, Cost and Trends, Alzheimer\u2019s Disease International."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/1756285612461679","article-title":"Current and future treatments for Alzheimer\u2019s disease","volume":"6","author":"Yiannopoulou","year":"2013","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"ref_3","first-page":"9","article-title":"Lecanemab in Early Alzheimer\u2019s Disease","volume":"388","author":"Swanson","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","article-title":"Donanemab in Early Alzheimer\u2019s Disease","volume":"384","author":"Mintun","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0140-6736(76)91936-X","article-title":"Selective loss of central cholinergic neurons in Alzheimer\u2019s disease","volume":"2","author":"Davies","year":"1976","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s40520-015-0321-8","article-title":"Evaluation of the cholinergic hypothesis in Alzheimer\u2019s disease with neuropsychological methods","volume":"27","author":"Fotiou","year":"2015","journal-title":"Aging Clin. Exp. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1570159X13666150716165726","article-title":"Alzheimer\u2019s disease: Targeting the Cholinergic System","volume":"14","author":"Guimaraes","year":"2016","journal-title":"Curr. Neuropharmacol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1126\/science.7058341","article-title":"Alzheimer\u2019s disease and senile dementia: Loss of neurons in the basal forebrain","volume":"215","author":"Whitehouse","year":"1982","journal-title":"Science"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF00697388","article-title":"Loss of neurons in the nucleus basalis of Meynert in Alzheimer\u2019s disease, paralysis agitans and Korsakoff\u2019s Disease","volume":"61","author":"Arendt","year":"1983","journal-title":"Acta Neuropathol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0197-4580(90)90056-6","article-title":"Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer\u2019s disease","volume":"11","author":"Vogels","year":"1990","journal-title":"Neurobiol. Aging"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0165-1781(79)90006-4","article-title":"Chronic Parkinsonism secondary to intravenous injection of meperidine analogues","volume":"1","author":"Davis","year":"1979","journal-title":"Psychiatry Res."},{"key":"ref_12","first-page":"145","article-title":"Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment","volume":"51","author":"DeKosky","year":"2002","journal-title":"Ann. Neurol. Off. J. Am. Neurol. Assoc. Child Neurol. Soc."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0014-4886(89)90124-6","article-title":"Loss of nerve growth factor receptor-containing neurons in Alzheimer\u2019s disease: A quantitative analysis across subregions of the basal forebrain","volume":"105","author":"Mufson","year":"1989","journal-title":"Exp. Neurol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/0024-3205(80)90176-9","article-title":"Acetylcholine and choline levels in post-mortem human brain tissue: Preliminary observations in Alzheimer\u2019s disease","volume":"26","author":"Richter","year":"1980","journal-title":"Life Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0006-8993(95)01477-2","article-title":"The basal forebrain cholinergic system and object memory in the rat","volume":"710","author":"Vnek","year":"1996","journal-title":"Brain Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1471-4159.1995.64020749.x","article-title":"Neurochemical correlates of dementia severity in Alzheimer\u2019s disease: Relative importance of the cholinergic deficits","volume":"64","author":"Bierer","year":"1995","journal-title":"J. Neurochem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41392-019-0063-8","article-title":"History and progress of hypotheses and clinical trials for Alzheimer\u2019s disease","volume":"4","author":"Liu","year":"2019","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Chen, Z.R., Huang, J.B., Yang, S.L., and Hong, F.F. (2022). Role of Cholinergic Signaling in Alzheimer\u2019s Disease. Molecules, 27.","DOI":"10.3390\/molecules27061816"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/cns.13035","article-title":"A review of clinical treatment considerations of donepezil in severe Alzheimer\u2019s disease","volume":"24","author":"Adlimoghaddam","year":"2018","journal-title":"CNS Neurosci. Ther."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0028-3908(65)90025-0","article-title":"Amnesic properties of scopolamine and brain acetylcholine in the rat","volume":"4","author":"Pazzagli","year":"1965","journal-title":"Int. J. Neuropharmacol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0091-3057(94)90227-5","article-title":"Nicotine reverses scopolamine-induced impairment of performance in passive avoidance task in rats through its action on the dopaminergic neuronal system","volume":"49","author":"Nitta","year":"1994","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00005072-199401000-00012","article-title":"192 IgG-saporin: I. Specific lethality for cholinergic neurons in the basal forebrain of the rat","volume":"53","author":"Book","year":"1994","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0166-4328(00)00262-X","article-title":"The role of cortical cholinergic afferent projections in cognition: Impact of new selective immunotoxins","volume":"115","author":"McGaughy","year":"2000","journal-title":"Behav. Brain Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0006-8993(94)91274-2","article-title":"Cortical cholinergic deafferentation following the intracortical infusion of 192 IgG-saporin: A quantitative histochemical study","volume":"663","author":"Holley","year":"1994","journal-title":"Brain Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1750-1326-8-37","article-title":"Modeling Alzheimer\u2019s disease in transgenic rats","volume":"8","author":"Cuello","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1037\/0735-7044.109.4.714","article-title":"Selective immunotoxic lesions of basal forebrain cholinergic cells: Effects on learning and memory in rats","volume":"109","author":"Baxter","year":"1995","journal-title":"Behav. Neurosci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1097\/00001756-199605310-00019","article-title":"Intact spatial learning following lesions of basal forebrain cholinergic neurons","volume":"7","author":"Baxter","year":"1996","journal-title":"Neuroreport"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0006-8993(99)02099-5","article-title":"Threshold relationship between lesion extent of the cholinergic basal forebrain in the rat and working memory impairment in the radial maze","volume":"847","author":"Wrenn","year":"1999","journal-title":"Brain Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1093\/brain\/awac093","article-title":"Structural (dys)connectivity associates with cholinergic cell density in Alzheimer\u2019s disease","volume":"145","author":"Lin","year":"2022","journal-title":"Brain"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/0197-4580(87)90131-X","article-title":"Alzheimer\u2019s disease as a presumptive threshold phenomenon","volume":"8","author":"Arendt","year":"1987","journal-title":"Neurobiol. Aging"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/0006-8993(90)90414-7","article-title":"Human striatal cholinergic neurons in development, aging and Alzheimer\u2019s disease","volume":"508","author":"Geula","year":"1990","journal-title":"Brain Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0896-6273(91)90052-2","article-title":"The molecular pathology of Alzheimer\u2019s disease","volume":"6","author":"Selkoe","year":"1991","journal-title":"Neuron"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","article-title":"Amyloid deposition as the central event in the aetiology of Alzheimer\u2019s disease","volume":"12","author":"Hardy","year":"1991","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.npep.2015.06.008","article-title":"Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer\u2019s disease","volume":"52","author":"Barage","year":"2015","journal-title":"Neuropeptides"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1126\/science.1197623","article-title":"Decreased clearance of CNS \u03b2-amyloid in Alzheimer\u2019s disease","volume":"330","author":"Mawuenyega","year":"2010","journal-title":"Science"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1038\/emboj.2012.79","article-title":"The mechanism of \u03b3-Secretase dysfunction in familial Alzheimer disease","volume":"31","author":"Bammens","year":"2012","journal-title":"Embo J."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/nm1295-1291","article-title":"The Swedish mutation causes early-onset Alzheimer\u2019s disease by \u03b2-secretase cleavage within the secretory pathway","volume":"1","author":"Haass","year":"1995","journal-title":"Nat. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2147\/CIA.S51571","article-title":"The genetics of Alzheimer\u2019s disease","volume":"9","author":"Bagyinszky","year":"2014","journal-title":"Clin. Interv. Aging"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1172\/JCI6179","article-title":"Expression of human apolipoprotein E reduces amyloid-\u03b2 deposition in a mouse model of Alzheimer\u2019s disease","volume":"103","author":"Holtzman","year":"1999","journal-title":"J. Clin. Investig."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/hmg\/ddh019","article-title":"Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: Evidence for augmentation of a 42-specific gamma secretase","volume":"13","author":"Jankowsky","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1093\/brain\/awt273","article-title":"Cell number changes in Alzheimer\u2019s disease relate to dementia, not to plaques and tangles","volume":"136","author":"Szczupak","year":"2013","journal-title":"Brain"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41583-018-0054-8","article-title":"Rodent models for Alzheimer disease","volume":"19","author":"Bodea","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00401-016-1662-x","article-title":"Alzheimer\u2019s disease: Experimental models and reality","volume":"133","author":"Drummond","year":"2017","journal-title":"Acta Neuropathol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease: Progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/373523a0","article-title":"Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein","volume":"373","author":"Games","year":"1995","journal-title":"Nature"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/35050103","article-title":"A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer\u2019s disease","volume":"408","author":"Chen","year":"2000","journal-title":"Nature"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","article-title":"Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: Potential factors in amyloid plaque formation","volume":"26","author":"Oakley","year":"2006","journal-title":"J. Neurosci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1093\/hmg\/ddh199","article-title":"Independent effects of APOE on cholesterol metabolism and brain Abeta levels in an Alzheimer disease mouse model","volume":"13","author":"Mann","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13024-019-0337-1","article-title":"Lack of hepatic apoE does not influence early A\u03b2 deposition: Observations from a new APOE knock-in model","volume":"14","author":"Huynh","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Wang, Z.-H., Xia, Y., Wu, Z., Kang, S.S., Zhang, J.-c., Liu, P., Liu, X., Song, W., Huin, V., and Dhaenens, C.-M. (2022). Neuronal ApoE4 stimulates C\/EBP\u03b2 activation, promoting Alzheimer\u2019s disease pathology in a mouse model. Prog. Neurobiol., 209.","DOI":"10.1016\/j.pneurobio.2021.102212"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/85064","article-title":"BACE1 is the major beta-secretase for generation of Abeta peptides by neurons","volume":"4","author":"Cai","year":"2001","journal-title":"Nat. Neurosci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1084\/jem.20171831","article-title":"BACE1 deletion in the adult mouse reverses preformed amyloid deposition and improves cognitive functions","volume":"215","author":"Hu","year":"2018","journal-title":"J. Exp. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"eaao5620","DOI":"10.1126\/scitranslmed.aao5620","article-title":"Axonal organization defects in the hippocampus of adult conditional BACE1 knockout mice","volume":"10","author":"Kurz","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.pmbts.2020.07.007","article-title":"Relevance of transgenic mouse models for Alzheimer\u2019s disease","volume":"177","author":"Tai","year":"2021","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"28257","DOI":"10.1074\/jbc.270.47.28257","article-title":"Levels and alternative splicing of amyloid beta protein precursor (APP) transcripts in brains of APP transgenic mice and humans with Alzheimer\u2019s disease","volume":"270","author":"Rockenstein","year":"1995","journal-title":"J. Biol. Chem."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"6483","DOI":"10.1074\/jbc.274.10.6483","article-title":"Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain","volume":"274","author":"Moechars","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"13287","DOI":"10.1073\/pnas.94.24.13287","article-title":"Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology","volume":"94","author":"Abramowski","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1523\/JNEUROSCI.5825-09.2010","article-title":"A mouse model of amyloid beta oligomers: Their contribution to synaptic alteration, abnormal tau phosphorylation, glial activation, and neuronal loss in vivo","volume":"30","author":"Tomiyama","year":"2010","journal-title":"J. Neurosci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1126\/science.274.5284.99","article-title":"Correlative memory deficits, A\u03b2 elevation, and amyloid plaques in transgenic mice","volume":"274","author":"Hsiao","year":"1996","journal-title":"Science"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0969-9961(03)00079-2","article-title":"Dendritic spine loss in the hippocampus of young PDAPP and Tg2576 mice and its prevention by the ApoE2 genotype","volume":"13","author":"Lanz","year":"2003","journal-title":"Neurobiol. Dis."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"5161","DOI":"10.1073\/pnas.0600948103","article-title":"Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer\u2019s disease","volume":"103","author":"Jacobsen","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1073\/pnas.96.6.3228","article-title":"Plaque-independent disruption of neural circuits in Alzheimer\u2019s disease mouse models","volume":"96","author":"Hsia","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"11393","DOI":"10.1523\/JNEUROSCI.2021-09.2009","article-title":"Abeta immunotherapy: Intracerebral sequestration of Abeta by an anti-Abeta monoclonal antibody 266 with high affinity to soluble Abeta","volume":"29","author":"Yamada","year":"2009","journal-title":"J. Neurosci."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1523\/JNEUROSCI.20-11-04050.2000","article-title":"High-level neuronal expression of abeta 1\u201342 in wild-type human amyloid protein precursor transgenic mice: Synaptotoxicity without plaque formation","volume":"20","author":"Mucke","year":"2000","journal-title":"J. Neurosci."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"11539","DOI":"10.1074\/jbc.M010977200","article-title":"Mutant presenilins disturb neuronal calcium homeostasis in the brain of transgenic mice, decreasing the threshold for excitotoxicity and facilitating long-term potentiation","volume":"276","author":"Schneider","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/383710a0","article-title":"Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1","volume":"383","author":"Duff","year":"1996","journal-title":"Nature"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"8717","DOI":"10.1523\/JNEUROSCI.20-23-08717.2000","article-title":"Presenilin-1 P264L Knock-In Mutation: Differential Effects on A\u03b2 Production, Amyloid Deposition, and Neuronal Vulnerability","volume":"20","author":"Siman","year":"2000","journal-title":"J. Neurosci."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nm0198-097","article-title":"Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes","volume":"4","author":"Holcomb","year":"1998","journal-title":"Nat. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0197-4580(01)00330-X","article-title":"FAD mutant PS-1 gene-targeted mice: Increased A beta 42 and A beta deposition without APP overproduction","volume":"23","author":"Flood","year":"2002","journal-title":"Neurobiol. Aging"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nn.2858","article-title":"Potent amyloidogenicity and pathogenicity of A\u03b243","volume":"14","author":"Saito","year":"2011","journal-title":"Nat. Neurosci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1023\/A:1021691918517","article-title":"Behavioral changes in transgenic mice expressing both amyloid precursor protein and presenilin-1 mutations: Lack of association with amyloid deposits","volume":"29","author":"Holcomb","year":"1999","journal-title":"Behav. Genet."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0896-6273(00)80974-5","article-title":"Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins","volume":"19","author":"Borchelt","year":"1997","journal-title":"Neuron"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.nbd.2004.10.022","article-title":"Episodic-like memory deficits in the APPswe\/PS1dE9 mouse model of Alzheimer\u2019s disease: Relationships to beta-amyloid deposition and neurotransmitter abnormalities","volume":"18","author":"Savonenko","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1471-4159.2007.05147.x","article-title":"Age-related decrease in stimulated glutamate release and vesicular glutamate transporters in APP\/PS1 transgenic and wild-type mice","volume":"105","author":"Minkeviciene","year":"2008","journal-title":"J. Neurochem."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000170884","article-title":"Expression of transgenic APP mRNA is the key determinant for beta-amyloid deposition in PS2APP transgenic mice","volume":"6","author":"Ozmen","year":"2009","journal-title":"Neurodegener. Dis."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"8989","DOI":"10.1523\/JNEUROSCI.23-26-08989.2003","article-title":"PS2APP transgenic mice, coexpressing hPS2mut and hAPPswe, show age-related cognitive deficits associated with discrete brain amyloid deposition and inflammation","volume":"23","author":"Richards","year":"2003","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"6452","DOI":"10.1523\/JNEUROSCI.20-17-06452.2000","article-title":"Aging increased amyloid peptide and caused amyloid plaques in brain of old APP\/V717I transgenic mice by a different mechanism than mutant presenilin1","volume":"20","author":"Dewachter","year":"2000","journal-title":"J. Neurosci."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1389-0344(01)00067-3","article-title":"Co-expression of multiple transgenes in mouse CNS: A comparison of strategies","volume":"17","author":"Jankowsky","year":"2001","journal-title":"Biomol. Eng."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer\u2019s disease with plaques and tangles: Intracellular Abeta and synaptic dysfunction","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.neuron.2005.01.040","article-title":"Intraneuronal Abeta causes the onset of early Alzheimer\u2019s disease-related cognitive deficits in transgenic mice","volume":"45","author":"Billings","year":"2005","journal-title":"Neuron"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bbr.2015.04.012","article-title":"Early detection of cognitive deficits in the 3xTg-AD mouse model of Alzheimer\u2019s disease","volume":"289","author":"Stover","year":"2015","journal-title":"Behav. Brain Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"196.e29","DOI":"10.1016\/j.neurobiolaging.2010.05.027","article-title":"Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal A\u03b2 aggregation in the 5XFAD mouse model of Alzheimer\u2019s disease","volume":"33","author":"Jawhar","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nn.3697","article-title":"Single App knock-in mouse models of Alzheimer\u2019s disease","volume":"17","author":"Saito","year":"2014","journal-title":"Nat. Neurosci."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"23380","DOI":"10.1074\/jbc.271.38.23380","article-title":"Enhanced amyloidogenic processing of the beta-amyloid precursor protein in gene-targeted mice bearing the Swedish familial Alzheimer\u2019s disease mutations and a \u201chumanized\u201d Abeta sequence","volume":"271","author":"Reaume","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"12754","DOI":"10.1074\/jbc.RA119.009487","article-title":"Humanization of the entire murine Mapt gene provides a murine model of pathological human tau propagation","volume":"294","author":"Saito","year":"2019","journal-title":"J. Biol. Chem."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1038\/s41467-019-10278-x","article-title":"Tau binding protein CAPON induces tau aggregation and neurodegeneration","volume":"10","author":"Hashimoto","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13024-020-00399-z","article-title":"Modeling the \u03b2-secretase cleavage site and humanizing amyloid-beta precursor protein in rat and mouse to study Alzheimer\u2019s disease","volume":"15","author":"Serneels","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Agca, C., Fritz, J.J., Walker, L.C., Levey, A.I., Chan, A.W., Lah, J.J., and Agca, Y. (2008). Development of transgenic rats producing human beta-amyloid precursor protein as a model for Alzheimer\u2019s disease: Transgene and endogenous APP genes are regulated tissue-specifically. BMC Neurosci., 9.","DOI":"10.1186\/1471-2202-9-28"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/ejn.12876","article-title":"Stereological estimation of neuron number and plaque load in the hippocampal region of a transgenic rat model of Alzheimer\u2019s disease","volume":"41","author":"Heggland","year":"2015","journal-title":"Eur. J. Neurosci."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3233\/JAD-2010-1349","article-title":"A novel transgenic rat model with a full Alzheimer\u2019s-like amyloid pathology displays pre-plaque intracellular amyloid-beta-associated cognitive impairment","volume":"20","author":"Leon","year":"2010","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"6245","DOI":"10.1523\/JNEUROSCI.3672-12.2013","article-title":"A transgenic Alzheimer rat with plaques, tau pathology, behavioral impairment, oligomeric a\u03b2, and frank neuronal loss","volume":"33","author":"Cohen","year":"2013","journal-title":"J. Neurosci."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Agca, C., Klakotskaia, D., Schachtman, T.R., Chan, A.W., Lah, J.J., and Agca, Y. (2016). Presenilin 1 transgene addition to amyloid precursor protein overexpressing transgenic rats increases amyloid beta 42 levels and results in loss of memory retention. BMC Neurosci., 17.","DOI":"10.1186\/s12868-016-0281-8"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.neurobiolaging.2017.09.024","article-title":"Anxiety-like behavior as an early endophenotype in the TgF344-AD rat model of Alzheimer\u2019s disease","volume":"61","author":"Pentkowski","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Klakotskaia, D., Agca, C., Richardson, R.A., Stopa, E.G., Schachtman, T.R., and Agca, Y. (2018). Memory deficiency, cerebral amyloid angiopathy, and amyloid-\u03b2 plaques in APP+PS1 double transgenic rat model of Alzheimer\u2019s disease. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0195469"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.neurobiolaging.2007.10.006","article-title":"A transgenic rat model of Alzheimer\u2019s disease with extracellular Abeta deposition","volume":"30","author":"Flood","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.nbd.2008.03.005","article-title":"A transgenic rat that develops Alzheimer\u2019s disease-like amyloid pathology, deficits in synaptic plasticity and cognitive impairment","volume":"31","author":"Liu","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3233\/JAD-2004-6301","article-title":"Rat transgenic models with a phenotype of intracellular A\u03b2 accumulation in hippocampus and cortex","volume":"6","author":"Echeverria","year":"2004","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"e13033","DOI":"10.1111\/acel.13033","article-title":"Facilitation of glutamate, but not GABA, release in Familial Alzheimer\u2019s APP mutant Knock-in rats with increased \u03b2-cleavage of APP","volume":"18","author":"Tambini","year":"2019","journal-title":"Aging Cell"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"e52612","DOI":"10.7554\/eLife.52612","article-title":"Opposite changes in APP processing and human A\u03b2 levels in rats carrying either a protective or a pathogenic APP mutation","volume":"9","author":"Tambini","year":"2020","journal-title":"Elife"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41422-021-00582-x","article-title":"An App knock-in rat model for Alzheimer\u2019s disease exhibiting A\u03b2 and tau pathologies, neuronal death and cognitive impairments","volume":"32","author":"Pang","year":"2022","journal-title":"Cell Res."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/s41588-021-00921-z","article-title":"A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer\u2019s disease","volume":"53","author":"Wightman","year":"2021","journal-title":"Nat. Genet."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1481.e7","DOI":"10.1016\/j.neurobiolaging.2011.12.007","article-title":"Genetic testing in familial and young-onset Alzheimer\u2019s disease: Mutation spectrum in a Serbian cohort","volume":"33","author":"Dobricic","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"13275","DOI":"10.1523\/JNEUROSCI.1034-15.2015","article-title":"Neuronal Store-Operated Calcium Entry and Mushroom Spine Loss in Amyloid Precursor Protein Knock-In Mouse Model of Alzheimer\u2019s Disease","volume":"35","author":"Zhang","year":"2015","journal-title":"J. Neurosci."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41514-020-00052-5","article-title":"Differential transcript usage unravels gene expression alterations in Alzheimer\u2019s disease human brains","volume":"7","author":"Iohan","year":"2021","journal-title":"NPJ Aging Mech. Dis."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.1038\/s41598-021-83872-z","article-title":"Defining early changes in Alzheimer\u2019s disease from RNA sequencing of brain regions differentially affected by pathology","volume":"11","author":"Guennewig","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13024-021-00429-4","article-title":"Remodeling Alzheimer-amyloidosis models by seeding","volume":"16","author":"Ulm","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1126\/science.1131864","article-title":"Exogenous Induction of Cerebral \u00df-Amyloidogenesis Is Governed by Agent and Host","volume":"313","author":"Coomaraswamy","year":"2006","journal-title":"Science"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1038\/s41380-022-01686-5","article-title":"Seed-induced A\u03b2 deposition alters neuronal function and impairs olfaction in a mouse model of Alzheimer\u2019s disease","volume":"27","author":"Friesen","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s40478-018-0549-6","article-title":"Environmental enrichment reverses A\u03b2 pathology during pregnancy in a mouse model of Alzheimer\u2019s disease","volume":"6","author":"Marksteiner","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/embor.2013.137","article-title":"Seeded strain-like transmission of \u03b2-amyloid morphotypes in APP transgenic mice","volume":"14","author":"Heilbronner","year":"2013","journal-title":"EMBO Rep."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","article-title":"Amyloid \u03b2 deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer\u2019s disease: A prospective cohort study","volume":"12","author":"Villemagne","year":"2013","journal-title":"Lancet Neurol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/22124","article-title":"Immunization with amyloid-\u03b2 attenuates Alzheimer-disease-like pathology in the PDAPP mouse","volume":"400","author":"Schenk","year":"1999","journal-title":"Nature"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/35050110","article-title":"A\u03b2 peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer\u2019s disease","volume":"408","author":"Janus","year":"2000","journal-title":"Nature"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/35050116","article-title":"A\u03b2 peptide vaccination prevents memory loss in an animal model of Alzheimer\u2019s disease","volume":"408","author":"Morgan","year":"2000","journal-title":"Nature"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3233\/JAD-142682","article-title":"Turning on the Light Within: Subcortical Nuclei of the Isodentritic Core and their Role in Alzheimer\u2019s Disease Pathogenesis","volume":"46","author":"Theofilas","year":"2015","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1056\/NEJMoa2304430","article-title":"Two Phase 3 Trials of Gantenerumab in Early Alzheimer\u2019s Disease","volume":"389","author":"Bateman","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nrn.2015.1","article-title":"Tau in physiology and pathology","volume":"17","author":"Wang","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00401-009-0532-1","article-title":"Classification and basic pathology of Alzheimer disease","volume":"118","author":"Duyckaerts","year":"2009","journal-title":"Acta Neuropathol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1146\/annurev-neuro-072116-031153","article-title":"Propagation of tau aggregates and neurodegeneration","volume":"40","author":"Goedert","year":"2017","journal-title":"Annu. Rev. Neurosci."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-017-0501-1","article-title":"Brainstem tau pathology in Alzheimer\u2019s disease is characterized by increase of three repeat tau and independent of amyloid \u03b2","volume":"6","author":"Uematsu","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1097\/NEN.0b013e318232a379","article-title":"Stages of the pathologic process in Alzheimer disease: Age categories from 1 to 100 years","volume":"70","author":"Braak","year":"2011","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1001\/archneur.55.3.326","article-title":"Clinicopathologic studies in cognitively healthy aging and Alzheimer disease: Relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype","volume":"55","author":"Berg","year":"1998","journal-title":"Arch. Neurol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1212\/01.WNL.0000063311.58879.01","article-title":"Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer\u2019s disease","volume":"60","author":"Giannakopoulos","year":"2003","journal-title":"Neurology"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/alz.12192","article-title":"Hypothesis: Tau pathology is an initiating factor in sporadic Alzheimer\u2019s disease","volume":"17","author":"Arnsten","year":"2021","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/78078","article-title":"Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein","volume":"25","author":"Lewis","year":"2000","journal-title":"Nat. Genet."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1126\/science.1058189","article-title":"Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP","volume":"293","author":"Lewis","year":"2001","journal-title":"Science"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nrn2420","article-title":"Animal models of Alzheimer\u2019s disease and frontotemporal dementia","volume":"9","author":"Ittner","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1126\/science.1113694","article-title":"Tau suppression in a neurodegenerative mouse model improves memory function","volume":"309","author":"Santacruz","year":"2005","journal-title":"Science"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","article-title":"Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model","volume":"53","author":"Yoshiyama","year":"2007","journal-title":"Neuron"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/s41593-018-0236-8","article-title":"Animal models of neurodegenerative diseases","volume":"21","author":"Dawson","year":"2018","journal-title":"Nat. Neurosci."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.3233\/JAD-170388","article-title":"Increased Vulnerability of the Hippocampus in Transgenic Mice Overexpressing APP and Triple Repeat Tau","volume":"61","author":"Arner","year":"2018","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/nan.12200","article-title":"Invited review: Animal models of tauopathies and their implications for research\/translation into the clinic","volume":"41","author":"Dujardin","year":"2015","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1046\/j.1471-4159.2003.01879.x","article-title":"Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms","volume":"86","author":"Andorfer","year":"2003","journal-title":"J. Neurochem."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1074\/jbc.M006531200","article-title":"Tau filament formation in transgenic mice expressing P301L tau","volume":"276","author":"Chen","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.nbd.2003.11.020","article-title":"Accelerated extinction of conditioned taste aversion in P301L tau transgenic mice","volume":"15","author":"Pennanen","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.neuron.2006.01.020","article-title":"M1 receptors play a central role in modulating AD-like pathology in transgenic mice","volume":"49","author":"Caccamo","year":"2006","journal-title":"Neuron"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"13357","DOI":"10.1523\/JNEUROSCI.2718-07.2007","article-title":"Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice","volume":"27","author":"Carroll","year":"2007","journal-title":"J. Neurosci."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1750-1326-8-2","article-title":"Neuron loss in the 5XFAD mouse model of Alzheimer\u2019s disease correlates with intraneuronal A\u03b242 accumulation and Caspase-3 activation","volume":"8","author":"Eimer","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1007\/s00429-014-0848-z","article-title":"Evidence for Alzheimer\u2019s disease-linked synapse loss and compensation in mouse and human hippocampal CA1 pyramidal neurons","volume":"220","author":"Neuman","year":"2015","journal-title":"Brain Struct. Funct."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0140-6736(85)90965-1","article-title":"A new definition of Alzheimer\u2019s disease: A hippocampal dementia","volume":"1","author":"Ball","year":"1985","journal-title":"Lancet"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"e2533","DOI":"10.1212\/WNL.0000000000207962","article-title":"Association of Pathologic and Volumetric Biomarker Changes With Cognitive Decline in Clinically Normal Adults","volume":"101","author":"Hanseeuw","year":"2023","journal-title":"Neurology"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1523\/JNEUROSCI.2642-12.2013","article-title":"Synthetic tau fibrils mediate transmission of neurofibrillary tangles in a transgenic mouse model of Alzheimer\u2019s-like tauopathy","volume":"33","author":"Iba","year":"2013","journal-title":"J. Neurosci."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.nbd.2014.08.032","article-title":"Intracerebral injection of preformed synthetic tau fibrils initiates widespread tauopathy and neuronal loss in the brains of tau transgenic mice","volume":"73","author":"Peeraer","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00401-014-1373-0","article-title":"Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer\u2019s disease or corticobasal degeneration brains","volume":"129","author":"Boluda","year":"2015","journal-title":"Acta Neuropathol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00401-018-1953-5","article-title":"Amyloid-\u03b2 pathology enhances pathological fibrillary tau seeding induced by Alzheimer PHF in vivo","volume":"137","author":"Vergara","year":"2019","journal-title":"Acta Neuropathol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"9535","DOI":"10.1073\/pnas.1301175110","article-title":"Brain homogenates from human tauopathies induce tau inclusions in mouse brain","volume":"110","author":"Clavaguera","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00401-015-1458-4","article-title":"Tau pathology spread in PS19 tau transgenic mice following locus coeruleus (LC) injections of synthetic tau fibrils is determined by the LC\u2019s afferent and efferent connections","volume":"130","author":"Iba","year":"2015","journal-title":"Acta Neuropathol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"eaaw6404","DOI":"10.1126\/sciadv.aaw6404","article-title":"Experimental evidence for the age dependence of tau protein spread in the brain","volume":"5","author":"Wegmann","year":"2019","journal-title":"Sci. Adv."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1021\/acschemneuro.0c00531","article-title":"Sowing the Seeds of Discovery: Tau-Propagation Models of Alzheimer\u2019s Disease","volume":"11","author":"Bell","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"443703","DOI":"10.3389\/fphar.2019.00189","article-title":"Experimental Pharmacology in Transgenic Rodent Models of Alzheimer\u2019s Disease","volume":"10","author":"Cuello","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s40142-019-0160-6","article-title":"Recent advances in the genetics of frontotemporal dementia","volume":"7","author":"Sirkis","year":"2019","journal-title":"Curr. Genet. Med. Rep."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/cen3.12475","article-title":"Neuroinflammation in mouse models of Alzheimer\u2019s disease","volume":"9","author":"Saito","year":"2018","journal-title":"Clin. Exp. Neuroimmunol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/jnc.13607","article-title":"Neuroinflammation: The devil is in the details","volume":"139","author":"DiSabato","year":"2016","journal-title":"J. Neurochem."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12974-018-1273-7","article-title":"APP21 transgenic rats develop age-dependent cognitive impairment and microglia accumulation within white matter tracts","volume":"15","author":"Weishaupt","year":"2018","journal-title":"J. Neuroinflamm."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13195-019-0491-2","article-title":"Neuroinflammation and amyloid-beta 40 are associated with reduced serotonin transporter (SERT) activity in a transgenic model of familial Alzheimer\u2019s disease","volume":"11","author":"Metaxas","year":"2019","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nn.3966","article-title":"GLUT1 reductions exacerbate Alzheimer\u2019s disease vasculo-neuronal dysfunction and degeneration","volume":"18","author":"Winkler","year":"2015","journal-title":"Nat. Neurosci."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nrn.2017.48","article-title":"Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease","volume":"18","author":"Kisler","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1742-2094-2-22","article-title":"Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP[V717I] transgenic mice","volume":"2","author":"Heneka","year":"2005","journal-title":"J. Neuroinflamm."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000283480","article-title":"Neuroinflammation\u2014An early event in both the history and pathogenesis of Alzheimer\u2019s disease","volume":"7","author":"Eikelenboom","year":"2010","journal-title":"Neurodegener. Dis."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1212\/01.wnl.0000338622.27876.0d","article-title":"Microglial activation and amyloid deposition in mild cognitive impairment: A PET study","volume":"72","author":"Okello","year":"2009","journal-title":"Neurology"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00401-009-0556-6","article-title":"Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer\u2019s disease","volume":"118","author":"Streit","year":"2009","journal-title":"Acta Neuropathol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","article-title":"Neuroinflammation and microglial activation in Alzheimer disease: Where do we go from here?","volume":"17","author":"Leng","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1742-2094-1-10","article-title":"Modelling neuroinflammatory phenotypes in vivo","volume":"1","author":"Buckwalter","year":"2004","journal-title":"J. Neuroinflamm."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.24272\/j.issn.2095-8137.2022.289","article-title":"Animal models of Alzheimer\u2019s disease: Applications, evaluation, and perspectives","volume":"43","author":"Chen","year":"2022","journal-title":"Zool. Res."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1023\/A:1022588808260","article-title":"Neurotoxic and synaptic effects of okadaic acid, an inhibitor of protein phosphatases","volume":"24","author":"Tapia","year":"1999","journal-title":"Neurochem. Res."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.bbr.2011.09.035","article-title":"Neuroglial alterations in rats submitted to the okadaic acid-induced model of dementia","volume":"226","author":"Costa","year":"2012","journal-title":"Behav. Brain Res."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.brainres.2009.10.064","article-title":"Okadaic acid (ICV) induced memory impairment in rats: A suitable experimental model to test anti-dementia activity","volume":"1309","author":"Kamat","year":"2010","journal-title":"Brain Res."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0197-4580(98)00003-7","article-title":"Phosphorylation of tau, Abeta-formation, and apoptosis after in vivo inhibition of PP-1 and PP-2A","volume":"19","author":"Arendt","year":"1998","journal-title":"Neurobiol. Aging"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/1742-2094-9-151","article-title":"Systemic immune challenges trigger and drive Alzheimer-like neuropathology in mice","volume":"9","author":"Krstic","year":"2012","journal-title":"J. Neuroinflamm."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1073\/pnas.040577797","article-title":"Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5","volume":"97","author":"Ahlijanian","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1523\/JNEUROSCI.5177-11.2012","article-title":"Cdk5\/p25-induced cytosolic PLA2-mediated lysophosphatidylcholine production regulates neuroinflammation and triggers neurodegeneration","volume":"32","author":"Sundaram","year":"2012","journal-title":"J. Neurosci."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.neuron.2016.05.003","article-title":"TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy","volume":"90","author":"Yuan","year":"2016","journal-title":"Neuron"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13024-015-0048-1","article-title":"Genetics ignite focus on microglial inflammation in Alzheimer\u2019s disease","volume":"10","author":"Malik","year":"2015","journal-title":"Mol. Neurodegener."},{"key":"ref_176","unstructured":"Stoker, T.B., and Greenland, J.C. (2018). Parkinson\u2019s Disease: Etiology, Neuropathology, and Pathogenesis. Parkinson\u2019s Disease: Pathogenesis and Clinical Aspects, Codon Publications."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.arr.2017.12.007","article-title":"The genetics of Parkinson disease","volume":"42","author":"Deng","year":"2018","journal-title":"Ageing Res. Rev."},{"key":"ref_178","first-page":"67","article-title":"Genetic basis of Parkinson\u2019s disease: Inheritance, penetrance, and expression","volume":"4","author":"Schulte","year":"2011","journal-title":"Appl. Clin. Genet."},{"key":"ref_179","first-page":"1234","article-title":"Neuropathology of dementia in patients with Parkinson\u2019s disease: A systematic review of autopsy studies","volume":"90","author":"Smith","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"\u03b1-Synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0022-510X(97)00100-7","article-title":"Correlation between neuromorphometry in the substantia nigra and clinical features in Parkinson\u2019s disease using disector counts","volume":"151","author":"Ma","year":"1997","journal-title":"J. Neurol. Sci."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3389\/fneur.2018.00455","article-title":"On Cell Loss and Selective Vulnerability of Neuronal Populations in Parkinson\u2019s Disease","volume":"9","author":"Trudeau","year":"2018","journal-title":"Front. Neurol."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1001\/archneur.63.4.584","article-title":"Motor Score of the Unified Parkinson Disease Rating Scale as a Good Predictor of Lewy Body\u2013Associated Neuronal Loss in the Substantia Nigra","volume":"63","author":"Greffard","year":"2006","journal-title":"Arch. Neurol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","article-title":"Ageing and Parkinson\u2019s disease: Substantia nigra regional selectivity","volume":"114","author":"Fearnley","year":"1991","journal-title":"Brain"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1093\/brain\/awt192","article-title":"Disease duration and the integrity of the nigrostriatal system in Parkinson\u2019s disease","volume":"136","author":"Kordower","year":"2013","journal-title":"Brain"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ana.21995","article-title":"Clinical progression in Parkinson disease and the neurobiology of axons","volume":"67","author":"Cheng","year":"2010","journal-title":"Ann. Neurol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF01249445","article-title":"Time course of nigrostriatal degeneration in parkinson\u2019s disease. A detailed study of influential factors in human brain amine analysis","volume":"38","author":"Riederer","year":"1976","journal-title":"J. Neural Transm."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","article-title":"Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlations","volume":"20","author":"Bernheimer","year":"1973","journal-title":"J. Neurol. Sci."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0166-4328(89)80121-4","article-title":"Selective lesion of central dopamine or noradrenaline neuron systems in the neonatal rat: Motor behavior and monoamine alterations at adult stage","volume":"33","author":"Luthman","year":"1989","journal-title":"Behav. Brain Res."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.freeradbiomed.2007.04.028","article-title":"6-Hydroxydopamine induces mitochondrial ERK activation","volume":"43","author":"Kulich","year":"2007","journal-title":"Free Radic. Biol. Med."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-201X.1971.tb11001.x","article-title":"Adipsia and Aphagia after 6-Hydroxydopamine Induced Degeneration of the Nigro-striatal Dopamine System","volume":"82","author":"Ungerstedt","year":"1971","journal-title":"Acta Physiol. Scand."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"982218","DOI":"10.3389\/fnbeh.2022.982218","article-title":"Longitudinal assessment of motor function following the unilateral intrastriatal 6-hydroxydopamine lesion model in mice","volume":"16","author":"Sun","year":"2022","journal-title":"Front. Behav. Neurosci."},{"key":"ref_194","first-page":"19","article-title":"MPTP mouse models of Parkinson\u2019s disease: An update","volume":"1","author":"Meredith","year":"2011","journal-title":"J. Park. Dis."},{"key":"ref_195","first-page":"135","article-title":"The parkinsonian toxin MPTP: Action and mechanism","volume":"16","author":"Przedborski","year":"2000","journal-title":"Restor. Neurol. Neurosci."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.expneurol.2006.02.002","article-title":"Rat model of Parkinson\u2019s disease: Chronic central delivery of 1-methyl-4-phenylpyridinium (MPP+)","volume":"200","author":"Yazdani","year":"2006","journal-title":"Exp. Neurol."},{"key":"ref_197","first-page":"600","article-title":"Similarities and differences between MPTP-induced parkinsonsim and Parkinson\u2019s disease. Neuropathologic considerations","volume":"60","author":"Forno","year":"1993","journal-title":"Adv. Neurol."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1073\/pnas.0409713102","article-title":"Parkinson-like syndrome induced by continuous MPTP infusion: Convergent roles of the ubiquitin-proteasome system and alpha-synuclein","volume":"102","author":"Fornai","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0166-4328(01)00309-6","article-title":"Behavioral phenotyping of the MPTP mouse model of Parkinson\u2019s disease","volume":"125","author":"Sedelis","year":"2001","journal-title":"Behav. Brain Res."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1476-5381.2011.01426.x","article-title":"Animal models of Parkinson\u2019s disease: A source of novel treatments and clues to the cause of the disease","volume":"164","author":"Duty","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.tins.2016.09.003","article-title":"\u03b1-Synuclein-based animal models of Parkinson\u2019s disease: Challenges and opportunities in a new era","volume":"39","author":"Visanji","year":"2016","journal-title":"Trends Neurosci."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nrn.2017.75","article-title":"Animal models of \u03b1-synucleinopathy for Parkinson disease drug development","volume":"18","author":"Koprich","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/7854_2014_355","article-title":"Transgenic rodent models to study alpha-synuclein pathogenesis, with a focus on cognitive deficits","volume":"22","author":"Hatami","year":"2015","journal-title":"Behav. Neurobiol. Huntington\u2019s Dis. Park. Dis."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/mds.25108","article-title":"Animal models of Parkinson\u2019s disease: Limits and relevance to neuroprotection studies","volume":"28","author":"Bezard","year":"2013","journal-title":"Mov. Disord."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"9248","DOI":"10.1523\/JNEUROSCI.1731-12.2012","article-title":"Conditional expression of Parkinson\u2019s disease-related mutant \u03b1-synuclein in the midbrain dopaminergic neurons causes progressive neurodegeneration and degradation of transcription factor nuclear receptor related 1","volume":"32","author":"Lin","year":"2012","journal-title":"J. Neurosci."},{"key":"ref_206","first-page":"271","article-title":"Viral vector-based models of Parkinson\u2019s disease","volume":"22","author":"Baekelandt","year":"2015","journal-title":"Behav. Neurobiol. Huntington\u2019s Dis. Park. Dis."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bbr.2015.03.058","article-title":"The 6-OHDA mouse model of Parkinson\u2019s disease\u2014Terminal striatal lesions provide a superior measure of neuronal loss and replacement than median forebrain bundle lesions","volume":"288","author":"Bagga","year":"2015","journal-title":"Behav. Brain Res."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0014-2999(77)90256-4","article-title":"Supersensitivity to apomorphine following destruction of the ascending dopamine neurons: Quantification using the rotational model","volume":"41","author":"Marshall","year":"1977","journal-title":"Eur. J. Pharmacol."},{"key":"ref_209","first-page":"S71","article-title":"Neuropathological staging of brain pathology in sporadic Parkinson\u2019s disease: Separating the wheat from the chaff","volume":"7","author":"Braak","year":"2017","journal-title":"J. Park. Dis."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3233\/JAD-180688","article-title":"Neuropathologic Correlates of Psychiatric Symptoms in Alzheimer\u2019s Disease","volume":"66","author":"Ehrenberg","year":"2018","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1007\/s10072-022-06068-x","article-title":"Anxiety and depression in Alzheimer\u2019s disease: A systematic review of pathogenetic mechanisms and relation to cognitive decline","volume":"43","author":"Botto","year":"2022","journal-title":"Neurol. Sci."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1136\/bmj.283.6306.1588","article-title":"Parkinson\u2019s disease and Alzheimer\u2019s disease as disorders of the isodendritic core","volume":"283","author":"Rossor","year":"1981","journal-title":"Br. Med. J. (Clin. Res. Ed.)"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/0306-4522(96)00163-7","article-title":"Global and serial neurons form A hierarchically arranged interface proposed to underlie memory and cognition","volume":"74","author":"Woolf","year":"1996","journal-title":"Neuroscience"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/cne.901260301","article-title":"The isodendritic core of the brain stem","volume":"126","author":"Nauta","year":"1966","journal-title":"J. Comp. Neurol."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0165-6147(99)01343-7","article-title":"Volume transmission in the CNS and its relevance for neuropsychopharmacology","volume":"20","author":"Zoli","year":"1999","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.brainresrev.2007.02.009","article-title":"From the Golgi\u2013Cajal mapping to the transmitter-based characterization of the neuronal networks leading to two modes of brain communication: Wiring and volume transmission","volume":"55","author":"Fuxe","year":"2007","journal-title":"Brain Res. Rev."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"e12274","DOI":"10.1002\/trc2.12274","article-title":"A novel process driving Alzheimer\u2019s disease validated in a mouse model: Therapeutic potential","volume":"8","author":"Greenfield","year":"2022","journal-title":"Alzheimer\u2019s Dement"},{"key":"ref_218","doi-asserted-by":"crossref","unstructured":"Garcia-Rat\u00e9s, S., and Greenfield, S. (2022). When a trophic process turns toxic: Alzheimer\u2019s disease as an aberrant recapitulation of a developmental mechanism. Int. J. Biochem. Cell Biol., 149.","DOI":"10.1016\/j.biocel.2022.106260"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0140-6736(82)91667-1","article-title":"Alzheimer\u2019s Disease as a Disorder of Isodendritic Core","volume":"319","author":"Bowen","year":"1982","journal-title":"Lancet"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/1531-8249(200101)49:1<53::AID-ANA30>3.0.CO;2-Q","article-title":"The selective vulnerability of brainstem nuclei to Alzheimer\u2019s disease","volume":"49","author":"Parvizi","year":"2001","journal-title":"Ann. Neurol."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF00686763","article-title":"Distribution of Alzheimer\u2019s neurofibrillary changes in the brain stem and hypothalamus of senile dementia","volume":"6","author":"Ishii","year":"1966","journal-title":"Acta Neuropathol."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/jnnp.52.2.193","article-title":"The substantia nigra and ventral tegmental area in Alzheimer\u2019s disease and Down\u2019s syndrome","volume":"52","author":"Gibb","year":"1989","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1046\/j.0305-1846.2000.00291.x","article-title":"The evolution of Alzheimer\u2019s disease-related cytoskeletal pathology in the human raphe nuclei","volume":"26","author":"Schultz","year":"2000","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.neurobiolaging.2006.02.007","article-title":"Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer\u2019s disease","volume":"28","author":"Grudzien","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s004019900178","article-title":"Evolution of Alzheimer\u2019s disease-related cytoskeletal changes in the basal nucleus of Meynert","volume":"100","author":"Sassin","year":"2000","journal-title":"Acta Neuropathol."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/00005072-198407000-00001","article-title":"Nucleus raphe dorsalis in dementia of the Alzheimer type: Neurofibrillary changes and neuronal packing density","volume":"43","author":"Curcio","year":"1984","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00005072-199801000-00008","article-title":"Relationship between plaques, tangles, and loss of cortical cholinergic fibers in Alzheimer disease","volume":"57","author":"Geula","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/BF00293315","article-title":"A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads","volume":"87","author":"Braak","year":"1994","journal-title":"Acta Neuropathol."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/ana.410240210","article-title":"The neuropathology of aminergic nuclei in Alzheimer\u2019s disease","volume":"24","author":"Zweig","year":"1988","journal-title":"Ann. Neurol."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/ana.20100","article-title":"Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum","volume":"55","author":"Mesulam","year":"2004","journal-title":"Ann. Neurol."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neurobiolaging.2021.11.006","article-title":"Locus coeruleus integrity is related to tau burden and memory loss in autosomal-dominant Alzheimer\u2019s disease","volume":"112","author":"Dahl","year":"2022","journal-title":"Neurobiol. Aging"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1365-2990.2008.00997.x","article-title":"The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer\u2019s disease. A precocious onset?","volume":"35","author":"Grinberg","year":"2009","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00401-006-0146-9","article-title":"Tau and alpha-synuclein brainstem pathology in Alzheimer disease: Relation with extrapyramidal signs","volume":"113","author":"Attems","year":"2007","journal-title":"Acta Neuropathol."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/archneur.60.3.337","article-title":"Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases","volume":"60","author":"Zarow","year":"2003","journal-title":"Arch. Neurol."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0022-510X(81)90031-9","article-title":"Cell loss in the locus coeruleus in senile dementia of Alzheimer type","volume":"49","author":"Tomlinson","year":"1981","journal-title":"J. Neurol. Sci."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/cne.902870308","article-title":"Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson\u2019s disease with and without dementia and depression","volume":"287","author":"Asan","year":"1989","journal-title":"J. Comp. Neurol."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00002093-199509020-00001","article-title":"Substantia nigra lesions in Alzheimer disease and normal aging","volume":"9","author":"Kazee","year":"1995","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0304-3940(95)12256-7","article-title":"Monoaminergic neurotransmitters, their precursors and metabolites in brains of Alzheimer patients","volume":"203","author":"Storga","year":"1996","journal-title":"Neurosci. Lett."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0006-8993(87)91408-9","article-title":"Monoaminergic innervation of the frontal and temporal lobes in Alzheimer\u2019s disease","volume":"401","author":"Palmer","year":"1987","journal-title":"Brain Res."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.neuropsychologia.2004.06.007","article-title":"Cholinergic-serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer\u2019s disease","volume":"43","author":"Chen","year":"2005","journal-title":"Neuropsychologia"},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.pneurobio.2012.06.010","article-title":"The serotonergic system in ageing and Alzheimer\u2019s disease","volume":"99","author":"Noristani","year":"2012","journal-title":"Prog. Neurobiol."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1523\/JNEUROSCI.22-08-03234.2002","article-title":"Cholinergic changes in the APP23 transgenic mouse model of cerebral amyloidosis","volume":"22","author":"Boncristiano","year":"2002","journal-title":"J. Neurosci."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1097\/00001756-200105250-00018","article-title":"Survival and plasticity of basal forebrain cholinergic systems in mice transgenic for presenilin-1 and amyloid precursor protein mutant genes","volume":"12","author":"Hernandez","year":"2001","journal-title":"Neuroreport"},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1006\/exnr.2001.7710","article-title":"Neuropathology of mice carrying mutant APP(swe) and\/or PS1(M146L) transgenes: Alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway","volume":"170","author":"Jaffar","year":"2001","journal-title":"Exp. Neurol."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/cne.10737","article-title":"Cholinergic neuropathology in a mouse model of Alzheimer\u2019s disease","volume":"462","author":"German","year":"2003","journal-title":"J. Comp. Neurol."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.nbd.2007.06.015","article-title":"Cholinergic forebrain degeneration in the APPswe\/PS1DeltaE9 transgenic mouse","volume":"28","author":"Perez","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1523\/JNEUROSCI.19-07-02706.1999","article-title":"Reorganization of cholinergic terminals in the cerebral cortex and hippocampus in transgenic mice carrying mutated presenilin-1 and amyloid precursor protein transgenes","volume":"19","author":"Wong","year":"1999","journal-title":"J. Neurosci."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11357-011-9343-0","article-title":"Age-related loss of noradrenergic neurons in the brains of triple transgenic mice","volume":"35","author":"Manaye","year":"2013","journal-title":"Age"},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jchemneu.2007.05.008","article-title":"Catecholaminergic neuronal loss in locus coeruleus of aged female dtg APP\/PS1 mice","volume":"34","author":"Mouton","year":"2007","journal-title":"J. Chem. Neuroanat."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13195-022-00994-w","article-title":"Chemical genetic activation of the cholinergic basal forebrain hippocampal circuit rescues memory loss in Alzheimer\u2019s disease","volume":"14","author":"Liu","year":"2022","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1007\/s11011-023-01242-2","article-title":"Imbalance of multiple neurotransmitter pathways leading to depression-like behavior and cognitive dysfunction in the triple transgenic mouse model of Alzheimer disease","volume":"38","author":"Zhang","year":"2023","journal-title":"Metab. Brain Dis."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"pyu020","DOI":"10.1093\/ijnp\/pyu020","article-title":"Depressive-like behavior is paired to monoaminergic alteration in a murine model of Alzheimer\u2019s disease","volume":"18","author":"Romano","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.neuroscience.2004.02.038","article-title":"Central cholinergic functions in human amyloid precursor protein knock-in\/presenilin-1 transgenic mice","volume":"125","author":"Hartmann","year":"2004","journal-title":"Neuroscience"},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/cne.20744","article-title":"The PDAPP mouse model of Alzheimer\u2019s disease: Locus coeruleus neuronal shrinkage","volume":"492","author":"German","year":"2005","journal-title":"J. Comp. Neurol."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s40478-023-01546-5","article-title":"Human tau-overexpressing mice recapitulate brainstem involvement and neuropsychiatric features of early Alzheimer\u2019s disease","volume":"11","author":"Khan","year":"2023","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0306-4522(03)00394-4","article-title":"The impact of Abeta-plaques on cortical cholinergic and non-cholinergic presynaptic boutons in alzheimer\u2019s disease-like transgenic mice","volume":"121","author":"Hu","year":"2003","journal-title":"Neuroscience"},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.neurobiolaging.2005.09.034","article-title":"The amyloid pathology progresses in a neurotransmitter-specific manner","volume":"27","author":"Bell","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.neuroscience.2004.11.047","article-title":"Selective cholinergic denervation, independent from oxidative stress, in a mouse model of Alzheimer\u2019s disease","volume":"132","author":"Aucoin","year":"2005","journal-title":"Neuroscience"},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.nbd.2009.06.004","article-title":"Brainstem Alzheimer\u2019s-like pathology in the triple transgenic mouse model of Alzheimer\u2019s disease","volume":"35","author":"Overk","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.neurobiolaging.2008.07.022","article-title":"Intracellular A\u03b2 triggers neuron loss in the cholinergic system of the APP\/PS1KI mouse model of Alzheimer\u2019s disease","volume":"31","author":"Christensen","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41597-021-01054-y","article-title":"Systematic phenotyping and characterization of the 5xFAD mouse model of Alzheimer\u2019s disease","volume":"8","author":"Forner","year":"2021","journal-title":"Sci. Data"},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.neubiorev.2020.02.012","article-title":"Behavioural and psychological symptoms of dementia in mouse models of Alzheimer\u2019s disease-related pathology","volume":"112","author":"Kosel","year":"2020","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.biopsych.2009.06.015","article-title":"Intraneuronal \u03b2-amyloid accumulation in the amygdala enhances fear and anxiety in Alzheimer\u2019s disease transgenic mice","volume":"67","author":"Valero","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"ref_264","doi-asserted-by":"crossref","unstructured":"Toda, T., Noda, Y., Ito, G., Maeda, M., and Shimizu, T. (2011). Presenilin-2 mutation causes early amyloid accumulation and memory impairment in a transgenic mouse model of Alzheimer\u2019s disease. BioMed Res. Int., 2011.","DOI":"10.1155\/2011\/617974"},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/sj.embor.7400784","article-title":"A\u03b242-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology","volume":"7","author":"Radde","year":"2006","journal-title":"EMBO Rep."},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0006-8993(00)03186-3","article-title":"Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes","volume":"891","author":"Arendash","year":"2001","journal-title":"Brain Res."},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.bbr.2013.12.028","article-title":"Targeting neurogenesis ameliorates danger assessment in a mouse model of Alzheimer\u2019s disease","volume":"261","author":"Shruster","year":"2014","journal-title":"Behav. Brain Res."},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.bbr.2012.07.004","article-title":"Cognitive and non-cognitive behaviors in the triple transgenic mouse model of Alzheimer\u2019s disease expressing mutated APP, PS1, and Mapt (3xTg-AD)","volume":"234","author":"Filali","year":"2012","journal-title":"Behav. Brain Res."},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.ajpath.2017.04.010","article-title":"Deficiency in ep4 receptor\u2013associated protein ameliorates abnormal anxiety-like behavior and brain inflammation in a mouse model of alzheimer disease","volume":"187","author":"Fujikawa","year":"2017","journal-title":"Am. J. Pathol."},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1037\/a0013607","article-title":"Limited impact of social isolation on Alzheimer-like symptoms in a triple transgenic mouse model","volume":"123","author":"Pietropaolo","year":"2009","journal-title":"Behav. Neurosci."},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bbr.2006.11.044","article-title":"Non-cognitive behaviours in an APP\/PS1 transgenic model of Alzheimer\u2019s disease","volume":"178","author":"Pugh","year":"2007","journal-title":"Behav. Brain Res."},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.neuroscience.2015.01.035","article-title":"Increased fragmentation of sleep\u2013wake cycles in the 5XFAD mouse model of Alzheimer\u2019s disease","volume":"290","author":"Sethi","year":"2015","journal-title":"Neuroscience"},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.expneurol.2012.05.011","article-title":"Effects of aging and genotype on circadian rhythms, sleep, and clock gene expression in APPxPS1 knock-in mice, a model for Alzheimer\u2019s disease","volume":"236","author":"Duncan","year":"2012","journal-title":"Exp. Neurol."},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.brainres.2010.05.013","article-title":"Characterization of the 3xTg-AD mouse model of Alzheimer\u2019s disease: Part 1. Circadian changes","volume":"1348","author":"Sterniczuk","year":"2010","journal-title":"Brain Res."},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF00712800","article-title":"A noncholinergic action of acetylcholinesterase (AChE) in the brain: From neuronal secretion to the generation of movement","volume":"11","author":"Greenfield","year":"1991","journal-title":"Cell Mol. Neurobiol."},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/35067589","article-title":"Acetylcholinesterase\u2014New roles for an old actor","volume":"2","author":"Soreq","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_277","doi-asserted-by":"crossref","unstructured":"Garcia Rat\u00e9s, S., Garc\u00eda-Ayll\u00f3n, M.-S., Falg\u00e0s, N., Brangman, S.A., Esiri, M.M., Coen, C.W., and Greenfield, S.A. (2024). Evidence for a novel neuronal mechanism driving Alzheimer\u2019s disease, upstream of amyloid. Alzheimer\u2019s Dement., Online ahead of print.","DOI":"10.1002\/alz.13869"},{"key":"ref_278","doi-asserted-by":"crossref","unstructured":"Greenfield, S.A., Ferrati, G., Coen, C.W., Vadisiute, A., Moln\u00e1r, Z., Garcia-Rates, S., Frautschy, S., and Cole, G.M. (2022). Characterization of a Bioactive Peptide T14 in the Human and Rodent Substantia Nigra: Implications for Neurodegenerative Disease. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232113119"},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.neuropharm.2016.02.006","article-title":"(I) Pharmacological profiling of a novel modulator of the \u03b17 nicotinic receptor: Blockade of a toxic acetylcholinesterase-derived peptide increased in Alzheimer brains","volume":"105","author":"Morrill","year":"2016","journal-title":"Neuropharmacology"},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3389\/fnins.2018.00362","article-title":"Modulatory Effects of a Novel Cyclized Peptide in Reducing the Expression of Markers Linked to Alzheimer\u2019s Disease","volume":"12","author":"Brai","year":"2018","journal-title":"Front. Neurosci."},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/cne.902750205","article-title":"Nucleus basalis (Ch4) and cortical cholinergic innervation in the human brain: Observations based on the distribution of acetylcholinesterase and choline acetyltransferase","volume":"275","author":"Mesulam","year":"1988","journal-title":"J. Comp. Neurol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/11\/6222\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:54:10Z","timestamp":1760108050000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/11\/6222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,5]]},"references-count":281,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["ijms25116222"],"URL":"https:\/\/doi.org\/10.3390\/ijms25116222","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,5]]}}}